相关实验视频

Updated: Jun 18, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

恩扎胺抑制PEX10功能,并使前列腺癌细胞对ROS激活剂敏感

Yuankang Feng¹, Yu Zhang¹, Hao Li¹

¹Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

Cell death & disease

|August 3, 2024

概括

反应性氧物种 (ROS) 在前列腺癌中起着不清楚的作用. 与ROS激活剂相结合的恩扎胺,通过向由雄激素受体 (AR) 调节的PEX10表达,显示出增强的抗瘤作用.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

反应性氧物种 (ROS) 涉及到细胞损伤,但它们在前列腺癌中的作用尚未完全理解.
恩扎胺是一种关键的抗前列腺癌药物,向雄激素受体 (AR).
了解恩扎胺的机制和优化其应用对于前列腺癌治疗至关重要.

研究的目的:

研究PEX10在前列腺癌细胞中的作用及其由ROS调节.
阐明恩扎胺对PEX10表达及其与AR相互作用的影响机制.
探索一种新的治疗策略,将恩扎胺与前列腺癌的ROS激活剂结合起来.

主要方法:

在ROS激活下,研究了前列腺癌细胞中的PEX10表达.
评估了ROS激活剂对PEX10水平和抗瘤活性的影响.
研究了受体 (AR) 与FOXA1.1结合对PEX10的调节.
评估了与ROS激活剂 (ML210,RSL3) 结合的恩扎胺的协同抗瘤作用.

主要成果:

PEX10由ROS激活剂诱导,但降低ROS水平,可能抵消抗瘤作用.
与FOXA1一起的雄激素受体 (AR) 增强了PEX10的表达.
恩扎胺通过阻断AR功能来抑制PEX10.
恩扎胺与ROS激活剂ML210或RSL3协同作用,增强抗瘤功效并使细胞对ROS激活剂敏感.

结论:

PEX10在前列腺癌细胞内的ROS水平调节中发挥作用.
恩扎胺抑制AR介导的PEX10表达提供了一个新的治疗途径.
将恩扎胺与ROS激活剂结合在一起,为增强前列腺癌治疗提供了一个有希望的策略.

更多相关视频

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...